Cargando…
Gradient differences of immunotherapy efficacy in metastatic melanoma related to sunlight exposure pattern: A population-based study
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized metastatic melanoma (MM) treatment in just a few years. Ultraviolet (UV) in sunlight is the most significant environmental cause of melanoma, which is considered to be the main reason for tumor mutation burden (TMB) increase in mela...
Autores principales: | Liu, Mengsong, Li, Wenyuan, Ma, Xiao, Che, Yuhui, Wei, Bo, Chen, Mulan, Zhong, Lin, Zhao, Siqi, Chen, Anjing, Pang, Yaobin, Zeng, Jinhao, Guo, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850161/ https://www.ncbi.nlm.nih.gov/pubmed/36686834 http://dx.doi.org/10.3389/fonc.2022.1086664 |
Ejemplares similares
-
The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021) -
Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study
por: Hadash-Bengad, Reut, et al.
Publicado: (2020) -
Editorial: The role of immunotherapy in melanomas
por: Fateeva, Anna, et al.
Publicado: (2023) -
High-Metastatic Melanoma Cells Promote the Metastatic Capability of Low-Metastatic Melanoma Cells via Exosomal Transfer of miR-411-5p
por: Chen, Hao, et al.
Publicado: (2022) -
Pilot Study of CT-Based Radiomics Model for Early Evaluation of Response to Immunotherapy in Patients With Metastatic Melanoma
por: Wang, Zhi-long, et al.
Publicado: (2020)